The Nordic region is home to the two highest ranked medical academic institutions in the European Union.
Eir Ventures Partners, a Sweden- and Denmark-based life science venture capital firm, has made a final close of its first fund from limited partners including healthcare company Novo and local universities.
Eir Ventures I fund raised €122.3m having made its initial close at €76m ($86m) in July last year to partner closely with universities across the Nordics and invest in their spinouts.
Other LPs include state-owned European Investment Fund (EIF), Saminvest and Vækstfonden, as well as Sustainable Development Umbrella…
